Munich, Germany

Cornelius Kloeck

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Leland Stanford Junior University. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cornelius Kloeck. Retrieved from https://idiyas.com/inventor/cornelius-kloeck

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

0

Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Cornelius Kloeck in Tissue Transglutaminase Modulation

Introduction

Cornelius Kloeck is an accomplished inventor based in Munich, Germany. He has made significant contributions to the field of biomedical research, particularly in the modulation of tissue transglutaminase (TG2) activation in various diseases. His innovative work aims to address inflammatory disorders through novel compositions and methods.

Latest Patents

Kloeck holds a patent titled "Modulation of tissue transglutaminase activation in disease." This patent focuses on compositions and methods for modulating the physiological activation of TG2. The methods described can include inhibiting the activity of TG2 associated with inflammatory disorders such as sepsis, ischemic reperfusion injury, and renal fibrosis.

Career Highlights

Cornelius Kloeck is affiliated with Leland Stanford Junior University, where he continues to advance his research in the biomedical field. His work has garnered attention for its potential impact on treating various inflammatory conditions.

Collaborations

Kloeck has collaborated with notable researchers, including Chaitan Khosla and Thomas DiRaimondo. These partnerships have further enriched his research endeavors and contributed to the advancement of knowledge in his area of expertise.

Conclusion

Cornelius Kloeck's innovative work in the modulation of tissue transglutaminase activation represents a significant advancement in the treatment of inflammatory disorders. His contributions continue to shape the future of biomedical research and therapeutic development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…